MovDisordV3, Main, Exploration, bibRecord, 004A98

Current issues in Tourette syndrome

Identifieur interne : 004A98 ( Main/Exploration ); précédent : 004A97; suivant : 004A99

Current issues in Tourette syndrome

Auteurs : Harvey S. Singer [États-Unis]

Source :

Movement Disorders [ 0885-3185 ] ; 2000-11.

RBID : ISTEX:663B89428350D7F8C39710CF0F16407A86DE23ED

Descripteurs français

Pascal (Inist)
- Article synthèse, Echelle évaluation, Evolution, Gilles de la Tourette syndrome, Homme, Phénoménologie, Tic.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Antipsychotic Agents (therapeutic use), Attention Deficit Disorder with Hyperactivity (drug therapy), Attention Deficit Disorder with Hyperactivity (epidemiology), Autoimmunity, Brain (immunology), Brain (metabolism), Brain (pathology), Brain (physiopathology), Central Nervous System Stimulants (therapeutic use), Comorbidity, Diagnosis, Differential, Evaluation scale, Evolution, Genetic Predisposition to Disease, Gilles de la Tourette syndrome, Human, Humans, Neurotransmitter Agents (agonists), Neurotransmitter Agents (antagonists & inhibitors), Neurotransmitter Agents (genetics), Neurotransmitter Agents (metabolism), Obsessive-Compulsive Disorder (epidemiology), Phenomenology, Prevalence, Review, Severity of Illness Index, Tic, Tic Disorders (diagnosis), Tic Disorders (epidemiology), Tourette Syndrome (diagnosis), Tourette Syndrome (drug therapy), Tourette Syndrome (epidemiology), Tourette Syndrome (metabolism).
MESH :
- chemical , agonists : Neurotransmitter Agents.
- chemical , antagonists & inhibitors : Neurotransmitter Agents.
- chemical , genetics : Neurotransmitter Agents.
- chemical , metabolism : Neurotransmitter Agents.
- chemical , therapeutic use : Antipsychotic Agents, Central Nervous System Stimulants.
- diagnosis : Tic Disorders, Tourette Syndrome.
- drug therapy : Attention Deficit Disorder with Hyperactivity, Tourette Syndrome.
- epidemiology : Attention Deficit Disorder with Hyperactivity, Obsessive-Compulsive Disorder, Tic Disorders, Tourette Syndrome.
- immunology : Brain.
- metabolism : Brain, Tourette Syndrome.
- pathology : Brain.
- physiopathology : Brain.
- Autoimmunity, Comorbidity, Diagnosis, Differential, Genetic Predisposition to Disease, Humans, Prevalence, Severity of Illness Index.

Url:

https://api.istex.fr/document/663B89428350D7F8C39710CF0F16407A86DE23ED/fulltext/pdf

DOI: 10.1002/1531-8257(200011)15:6<1051::AID-MDS1001>3.0.CO;2-L

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Current issues in Tourette syndrome</title>
<author><name sortKey="Singer, Harvey S" sort="Singer, Harvey S" uniqKey="Singer H" first="Harvey S." last="Singer">Harvey S. Singer</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:663B89428350D7F8C39710CF0F16407A86DE23ED</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1002/1531-8257(200011)15:6<1051::AID-MDS1001>3.0.CO;2-L</idno>
<idno type="url">https://api.istex.fr/document/663B89428350D7F8C39710CF0F16407A86DE23ED/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002578</idno>
<idno type="wicri:Area/Istex/Curation">002578</idno>
<idno type="wicri:Area/Istex/Checkpoint">003299</idno>
<idno type="wicri:doubleKey">0885-3185:2000:Singer H:current:issues:in</idno>
<idno type="wicri:Area/Main/Merge">007396</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:01-0016539</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002A98</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000223</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002C28</idno>
<idno type="wicri:doubleKey">0885-3185:2000:Singer H:current:issues:in</idno>
<idno type="wicri:Area/Main/Merge">007620</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:11104186</idno>
<idno type="wicri:Area/PubMed/Corpus">003E79</idno>
<idno type="wicri:Area/PubMed/Curation">003E79</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004007</idno>
<idno type="wicri:Area/Ncbi/Merge">000372</idno>
<idno type="wicri:Area/Ncbi/Curation">000372</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000372</idno>
<idno type="wicri:doubleKey">0885-3185:2000:Singer H:current:issues:in</idno>
<idno type="wicri:Area/Main/Merge">007150</idno>
<idno type="wicri:Area/Main/Curation">004A98</idno>
<idno type="wicri:Area/Main/Exploration">004A98</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Current issues in Tourette syndrome</title>
<author><name sortKey="Singer, Harvey S" sort="Singer, Harvey S" uniqKey="Singer H" first="Harvey S." last="Singer">Harvey S. Singer</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Neurology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>John Wiley & Sons, Inc.</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2000-11">2000-11</date>
<biblScope unit="vol">15</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="1051">1051</biblScope>
<biblScope unit="page" to="1063">1063</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">663B89428350D7F8C39710CF0F16407A86DE23ED</idno>
<idno type="DOI">10.1002/1531-8257(200011)15:6<1051::AID-MDS1001>3.0.CO;2-L</idno>
<idno type="ArticleID">MDS1001</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antipsychotic Agents (therapeutic use)</term>
<term>Attention Deficit Disorder with Hyperactivity (drug therapy)</term>
<term>Attention Deficit Disorder with Hyperactivity (epidemiology)</term>
<term>Autoimmunity</term>
<term>Brain (immunology)</term>
<term>Brain (metabolism)</term>
<term>Brain (pathology)</term>
<term>Brain (physiopathology)</term>
<term>Central Nervous System Stimulants (therapeutic use)</term>
<term>Comorbidity</term>
<term>Diagnosis, Differential</term>
<term>Evaluation scale</term>
<term>Evolution</term>
<term>Genetic Predisposition to Disease</term>
<term>Gilles de la Tourette syndrome</term>
<term>Human</term>
<term>Humans</term>
<term>Neurotransmitter Agents (agonists)</term>
<term>Neurotransmitter Agents (antagonists & inhibitors)</term>
<term>Neurotransmitter Agents (genetics)</term>
<term>Neurotransmitter Agents (metabolism)</term>
<term>Obsessive-Compulsive Disorder (epidemiology)</term>
<term>Phenomenology</term>
<term>Prevalence</term>
<term>Review</term>
<term>Severity of Illness Index</term>
<term>Tic</term>
<term>Tic Disorders (diagnosis)</term>
<term>Tic Disorders (epidemiology)</term>
<term>Tourette Syndrome (diagnosis)</term>
<term>Tourette Syndrome (drug therapy)</term>
<term>Tourette Syndrome (epidemiology)</term>
<term>Tourette Syndrome (metabolism)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="agonists" xml:lang="en"><term>Neurotransmitter Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Neurotransmitter Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Neurotransmitter Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Neurotransmitter Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antipsychotic Agents</term>
<term>Central Nervous System Stimulants</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Tic Disorders</term>
<term>Tourette Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Attention Deficit Disorder with Hyperactivity</term>
<term>Tourette Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Attention Deficit Disorder with Hyperactivity</term>
<term>Obsessive-Compulsive Disorder</term>
<term>Tic Disorders</term>
<term>Tourette Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Brain</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Brain</term>
<term>Tourette Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Brain</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Autoimmunity</term>
<term>Comorbidity</term>
<term>Diagnosis, Differential</term>
<term>Genetic Predisposition to Disease</term>
<term>Humans</term>
<term>Prevalence</term>
<term>Severity of Illness Index</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Article synthèse</term>
<term>Echelle évaluation</term>
<term>Evolution</term>
<term>Gilles de la Tourette syndrome</term>
<term>Homme</term>
<term>Phénoménologie</term>
<term>Tic</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Maryland</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Maryland"><name sortKey="Singer, Harvey S" sort="Singer, Harvey S" uniqKey="Singer H" first="Harvey S." last="Singer">Harvey S. Singer</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004A98 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004A98 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:663B89428350D7F8C39710CF0F16407A86DE23ED
   |texte=   Current issues in Tourette syndrome
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Current issues in Tourette syndrome

Current issues in Tourette syndrome

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.